1 / 4

Healthkart’s scale spikes 2.7X to Rs 832 Cr in last two fiscals

Healthkart had witnessed flat growth in scale during FY18-FY21 period but the company has rediscovered its growth surge in the past two years. The nutrition firmu2019s revenue flew 2.7X to Rs 832 crore in FY23 from Rs 307 crore in FY21 with significant improvement in unit economics.

Entrackr
Télécharger la présentation

Healthkart’s scale spikes 2.7X to Rs 832 Cr in last two fiscals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. scale spikes 2.7X to Rs 832 Cr in last two fiscals

  2. Introduction • Healthkart had witnessed flat growth in scale during FY18-FY21 period but the company has rediscovered its growth surge in the past two years. • The nutrition firm’s revenue flew 2.7X to Rs 832 crore in FY23 from Rs 307 crore in FY21 with significant improvement in unit economics. Healthkart Financial FY23

  3. Healthkart’s revenue from operations grew by 60.45% to Rs 832 crore in FY23 from Rs 491 crore in FY22, its consolidated financial statements sourced from the Registrar of Companies- as per Entrackr report. • In December last year, Healthkart claimed that MuscleBlaze controlled 25% share of India’s sports nutrition market whereas HKVitals had controlled 20% share of the online health supplement market. Healthkart Expense Breakdown

  4. Its employee benefits, transportation, commission to agents, information technology, legal-professional, and other overheads catalyzed the total expenditure by 60.94% to Rs 927 crore in FY23. Healthkart FY22- FY23 • The decent scale helped Healthkart to manage its losses, which saw a modest 10% increase to Rs 76 crore in FY23 as compared to Rs 69 crore in FY22. • Its ROCE and EBITDA improved to -22% and -16% respectively. On a unit level, the company spent Rs 1.11 to earn a rupee in FY23. • Get the complete information HERE.

More Related